Resveratrol protects against postmenopausal atherosclerosis progression through reducing PCSK9 expression via the regulation of the ERα-mediated signaling pathway-Reference-Cited by-同舟云学术

Resveratrol protects against postmenopausal atherosclerosis progression through reducing PCSK9 expression via the regulation of the ERα-mediated signaling pathway

Published:2023-05 Issue: Volume:211 Page:115541
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Jing Yi,Hu Tianhui,Yuan Jun,Liu Zhikun,Tao Mingtao,Ou Mingyu,Cheng Xinru,Cheng Wei,Yi Yuanyuan,Xiong Qingping

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference50 articles.

1. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes;Regitz-Zagrosek;Eur. Heart J.,2016

2. Influence of age and menopause on serum lipids and lipoproteins in healthy women;Stevenson;Atherosclerosis,1993

3. Hormone replacement therapy in postmenopausal women and its effects on plasma lipid levels;Erberich;Clin. Chem. Lab. Med.,2002

4. Regulation of plasma low density lipoprotein levels in postmenopausal women;Karjalainen;Atherosclerosis,2000

5. Serum PCSK9 is associated with multiple metabolic factors in a large Han Chinese population;Cui;Atherosclerosis,2010

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural phytochemicals as small-molecule proprotein convertase subtilisin/kexin type 9 inhibitors;Tzu Chi Medical Journal;2024-09-05

2. New potential selective estrogen receptor modulators in traditional Chinese medicine for treating menopausal syndrome;Phytotherapy Research;2024-08-09

3. Qixian granule inhibits ferroptosis in vascular endothelial cells by modulating TRPML1 in the lysosome to prevent postmenopausal atherosclerosis;Journal of Ethnopharmacology;2024-06

4. A promising therapy for fatty liver disease: PCSK9 inhibitors;Phytomedicine;2024-06